Display Settings:

Format

Send to:

Choose Destination
    Clin Infect Dis. 2003 Aug 1;37(3):450-1. Epub 2003 Jul 18.

    Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.

    Source

    Center for Geographic Medicine and Department of Medicine, Chaim Sheba Medical Center, Tel Hashomer, Israel.

    Abstract

    We report a case of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to Kenya. Recurrent parasitemia occurred 30 days after directly observed therapy with a combination of atovaquone and proguanil. Treatment failure was confirmed by genetic fingerprinting and sequencing. The primary isolate had wild-type sequence of cytochrome b; however, the recrudescent isolate had a single mutation at position 268 (Tyr268Ser).

    PMID:
    12884171
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Click here to read

      Chemical compound information

      See 3 citations for this compound....

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk